MedPath

Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke

Phase 3
Completed
Conditions
Post-stroke Spasticity of the Upper Limb
Interventions
Registration Number
NCT01392300
Lead Sponsor
Merz Pharmaceuticals GmbH
Brief Summary

The purpose of this study is to determine whether injections of Botulinum toxin type A into muscles of the upper limb are effective in treating spasticity in patients after stroke.

Detailed Description

The study consists of a randomized, double-blind, placebo-controlled, parallel-group, single-dose main period followed by an open-label, non-controlled, repeated-dose extension period (Open-Label Extension Period - OLEX).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
317
Inclusion Criteria
  • Upper limb spasticity
  • Time since stroke greater than 3 months
  • Need for 400 U Botulinum toxin type A
Read More
Exclusion Criteria
  • Body weight below 50kg
  • Fixed contractures of the upper limb
  • Generalized disorders of muscle activity like Myasthenia gravis that preclude use of Botulinum toxin Type A
  • Infection at the injection site
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
DB Placebo ComparatorPlacebo ComparatorPlacebo to incobotulinumtoxinA (Xeomin) (400 Units): Main period, one injection session - double-blind (DB), randomized treatment assignment
DB IncobotulinumtoxinA (Xeomin) (400 U)IncobotulinumtoxinA (400 Units)IncobotulinumtoxinA (Xeomin) (400 Units): Main period, one injection session - double-blind (DB), randomized treatment assignment
Primary Outcome Measures
NameTimeMethod
Change From Baseline in Ashworth Scale (AS) Score of Primary Target Clinical PatternWeek 4

Primary target clinical pattern was defined by investigator for each subject at baseline visit and was either flexed wrist or clenched fist or flexed elbow.

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension).

Investigator's Global Impression of ChangeWeek 4

This is the co-primary outcome measure. The Global Impression of Change Scale \[GICS\] is used to measure the investigator's impression of change due to treatment. The response option is a common 7-point Likert scale that ranges from -3 = very much worse to +3 = very much improved.

Secondary Outcome Measures
NameTimeMethod
Response Rates on the Ashworth Scale at Week 4 Calculated for the Muscle Group Flexed ElbowWeek 4

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension). Subjects with a reduction of one point were defined as responder for the aim of the efficacy analysis.

Response Rates on the Ashworth Scale at Week 8 Calculated for the Muscle Group Flexed ElbowWeek 8

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension). Subjects with a reduction of one point were defined as responder for the aim of the efficacy analysis.

Response Rates on the Ashworth Scale at Week 4 Calculated for the Primary Target Clinical PatternWeek 4

Primary target clinical pattern was defined by investigator for each subject at baseline visit and was either flexed wrist or clenched fist or flexed elbow. Subjects with a reduction of one point were defined as responder for the aim of the efficacy analysis.

Response Rates on the Ashworth Scale at Week 8 Calculated for the Primary Target Clinical PatternWeek 8

Primary target clinical pattern was defined by investigator for each subject at baseline visit and was either flexed wrist or clenched fist or flexed elbow. Subjects with a reduction of one point were defined as responder for the aim of the efficacy analysis.

Response Rates on the Ashworth Scale at Week 8 Calculated for the Muscle Group Flexed WristWeek 8

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension). Subjects with a reduction of one point were defined as responder for the aim of the efficacy analysis.

Response Rates on the Ashworth Scale at Week 12 Calculated for the Primary Target Clinical PatternWeek 12

Primary target clinical pattern was defined by investigator for each subject at baseline visit and was either flexed wrist or clenched fist or flexed elbow. Subjects with a reduction of one point were defined as responder for the aim of the efficacy analysis.

Response Rates on the Ashworth Scale at Week 12 Calculated for the Muscle Group Flexed WristWeek 12

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension). Subjects with a reduction of one point were defined as responder for the aim of the efficacy analysis.

Response Rates on the Ashworth Scale at Week 4 Calculated for the Muscle Group Flexed WristWeek 4

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension). Subjects with a reduction of one point were defined as responder for the aim of the efficacy analysis.

Response Rates on the Ashworth Scale at Week 12 Calculated for the Muscle Group Flexed ElbowWeek 12

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension). Subjects with a reduction of one point were defined as responder for the aim of the efficacy analysis.

Response Rates on the Ashworth Scale at Week 4 Calculated for the Muscle Group Clenched FistWeek 4

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension). Subjects with a reduction of one point were defined as responder for the aim of the efficacy analysis.

Response Rates on the Ashworth Scale at Week 8 Calculated for the Muscle Group Clenched FistWeek 8

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension). Subjects with a reduction of one point were defined as responder for the aim of the efficacy analysis.

Response Rates on the Ashworth Scale at Week 12 Calculated for the Muscle Group Clenched FistWeek 12

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension). Subjects with a reduction of one point were defined as responder for the aim of the efficacy analysis.

Response Rates on the Ashworth Scale at Week 4 Calculated for the Muscle Group Thumb-in-palmWeek 4

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension). Subjects with a reduction of one point were defined as responder for the aim of the efficacy analysis.

Response Rates on the Ashworth Scale at Week 8 Calculated for the Muscle Group Thumb-in-palmWeek 8

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension). Subjects with a reduction of one point were defined as responder for the aim of the efficacy analysis.

Response Rates on the Ashworth Scale at Week 12 Calculated for the Muscle Group Thumb-in-palmWeek 12

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension). Subjects with a reduction of one point were defined as responder for the aim of the efficacy analysis.

Response Rates on the Ashworth Scale at Week 4 Calculated for the Muscle Group Pronated ForearmWeek 4

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension). Subjects with a reduction of one point were defined as responder for the aim of the efficacy analysis.

Response Rates on the Ashworth Scale at Week 8 Calculated for the Muscle Group Pronated ForearmWeek 8

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension). Subjects with a reduction of one point were defined as responder for the aim of the efficacy analysis.

Response Rates on the Ashworth Scale at Week 12 Calculated for the Muscle Group Pronated ForearmWeek 12

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension). Subjects with a reduction of one point were defined as responder for the aim of the efficacy analysis.

Changes From Baseline to Week 4 in Ashworth Scale Score for Treated Muscle Group Flexed Wrist.Week 4

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension).

Changes From Baseline to Week 8 in Ashworth Scale Score for Treated Muscle Group Flexed Wrist.Week 8

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension).

Changes From Baseline to Week 12 in Ashworth Scale Score for Treated Muscle Group Flexed Wrist.Week 12

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension).

Changes From Baseline to Week 4 in Ashworth Scale Score for Treated Muscle Group Flexed Elbow.Week 4

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension).

Changes From Baseline to Week 8 in Ashworth Scale Score for Treated Muscle Group Flexed Elbow.Week 8

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension).

Changes From Baseline to Week 12 in Ashworth Scale Score for Treated Muscle Group Flexed Elbow.Week 12

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension).

Changes From Baseline to Week 4 in Ashworth Scale Score for Treated Muscle Group Clenched Fist.Week 4

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension).

Changes From Baseline to Week 8 in Ashworth Scale Score for Treated Muscle Group Clenched Fist.Week 8

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension).

Changes From Baseline to Week 12 in Ashworth Scale Score for Treated Muscle Group Clenched Fist.Week 12

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension).

Changes From Baseline to Week 4 in Ashworth Scale Score for Treated Muscle Group Thumb-in-palm.Week 4

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension).

Changes From Baseline to Week 8 in Ashworth Scale Score for Treated Muscle Group Thumb-in-palm.Week 8

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension).

Changes From Baseline to Week 12 in Ashworth Scale Score for Treated Muscle Group Thumb-in-palm.Week 12

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension).

Changes From Baseline to Week 4 in Ashworth Scale Score for Treated Muscle Group Pronated Forearm.Week 4

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension).

Changes From Baseline to Week 8 in Ashworth Scale Score for Treated Muscle Group Pronated Forearm.Week 8

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension).

Changes From Baseline to Week 12 in Ashworth Scale Score for Treated Muscle Group Pronated Forearm.Week 12

The Ashworth Scale is well known and commonly used in clinical trials with spasticity. It was used to categorize severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension).

Changes From Baseline to Week 4 in Disability Assessment Scale - Principal Therapeutic Target DomainWeek 4

The Disability Assessment Scale consists of the four domains hygiene, dressing, limb position, and pain which were assessed on a 4-point scale with the values 0 (=no disability), 1 (=mild disability), 2 (=moderate disability), and 3 (=severe disability).

Changes From Baseline to Week 8 in Disability Assessment Scale - Principal Therapeutic Target DomainWeek 8

The Disability Assessment Scale consists of the four domains hygiene, dressing, limb position, and pain which were assessed on a 4-point scale with the values 0 (=no disability), 1 (=mild disability), 2 (=moderate disability), and 3 (=severe disability).

Changes From Baseline to Week 12 in Disability Assessment Scale - Principal Therapeutic Target DomainWeek 12

The Disability Assessment Scale consists of the four domains hygiene, dressing, limb position, and pain which were assessed on a 4-point scale with the values 0 (=no disability), 1 (=mild disability), 2 (=moderate disability), and 3 (=severe disability).

Changes From Baseline to Week 4 in Disability Assessment Scale - Domain HygieneWeek 4

The Disability Assessment Scale consists of the four domains hygiene, dressing, limb position, and pain which were assessed on a 4-point scale with the values 0 (=no disability), 1 (=mild disability), 2 (=moderate disability), and 3 (=severe disability).

Changes From Baseline to Week 8 in Disability Assessment Scale - Domain HygieneWeek 8

The Disability Assessment Scale consists of the four domains hygiene, dressing, limb position, and pain which were assessed on a 4-point scale with the values 0 (=no disability), 1 (=mild disability), 2 (=moderate disability), and 3 (=severe disability).

Changes From Baseline to Week 12 in Disability Assessment Scale - Domain HygieneWeek 12

The Disability Assessment Scale consists of the four domains hygiene, dressing, limb position, and pain which were assessed on a 4-point scale with the values 0 (=no disability), 1 (=mild disability), 2 (=moderate disability), and 3 (=severe disability).

Changes From Baseline to Week 4 in Disability Assessment Scale - Domain DressingWeek 4

The Disability Assessment Scale consists of the four domains hygiene, dressing, limb position, and pain which were assessed on a 4-point scale with the values 0 (=no disability), 1 (=mild disability), 2 (=moderate disability), and 3 (=severe disability).

Changes From Baseline to Week 8 in Disability Assessment Scale - Domain DressingWeek 8

The Disability Assessment Scale consists of the four domains hygiene, dressing, limb position, and pain which were assessed on a 4-point scale with the values 0 (=no disability), 1 (=mild disability), 2 (=moderate disability), and 3 (=severe disability).

Changes From Baseline to Week 12 in Disability Assessment Scale - Domain DressingWeek 12

The Disability Assessment Scale consists of the four domains hygiene, dressing, limb position, and pain which were assessed on a 4-point scale with the values 0 (=no disability), 1 (=mild disability), 2 (=moderate disability), and 3 (=severe disability).

Changes From Baseline to Week 4 in Disability Assessment Scale - Domain Limb PositionWeek 4

The Disability Assessment Scale consists of the four domains hygiene, dressing, limb position, and pain which were assessed on a 4-point scale with the values 0 (=no disability), 1 (=mild disability), 2 (=moderate disability), and 3 (=severe disability).

Changes From Baseline to Week 8 in Disability Assessment Scale - Domain Limb PositionWeek 8

The Disability Assessment Scale consists of the four domains hygiene, dressing, limb position, and pain which were assessed on a 4-point scale with the values 0 (=no disability), 1 (=mild disability), 2 (=moderate disability), and 3 (=severe disability).

Changes From Baseline to Week 12 in Disability Assessment Scale - Domain Limb PositionWeek 12

The Disability Assessment Scale consists of the four domains hygiene, dressing, limb position, and pain which were assessed on a 4-point scale with the values 0 (=no disability), 1 (=mild disability), 2 (=moderate disability), and 3 (=severe disability).

Changes From Baseline to Week 4 in Disability Assessment Scale - Domain PainWeek 4

The Disability Assessment Scale consists of the four domains hygiene, dressing, limb position, and pain which were assessed on a 4-point scale with the values 0 (=no disability), 1 (=mild disability), 2 (=moderate disability), and 3 (=severe disability).

Changes From Baseline to Week 8 in Disability Assessment Scale - Domain PainWeek 8

The Disability Assessment Scale consists of the four domains hygiene, dressing, limb position, and pain which were assessed on a 4-point scale with the values 0 (=no disability), 1 (=mild disability), 2 (=moderate disability), and 3 (=severe disability).

Changes From Baseline to Week 12 in Disability Assessment Scale - Domain PainWeek 12

The Disability Assessment Scale consists of the four domains hygiene, dressing, limb position, and pain which were assessed on a 4-point scale with the values 0 (=no disability), 1 (=mild disability), 2 (=moderate disability), and 3 (=severe disability).

Trial Locations

Locations (47)

Merz Investigational Site # 001110

🇺🇸

Overland Park, Kansas, United States

Merz Investigational Site #001245

🇺🇸

Chattanooga, Tennessee, United States

Merz Investigational Site #420030

🇨🇿

Praha, Czech Republic

Merz Investigational Site #048053

🇵🇱

Poznan, Poland

Merz Investigational Site #091007

🇮🇳

Chennai, Tamil Nadu, India

Merz Investigational Site #091008

🇮🇳

Coimbatore, Tamil Nadu, India

Merz Investigational Site #001188

🇺🇸

Miami, Florida, United States

Merz Investigational Site # 048029

🇵🇱

Gdansk, Poland

Merz Investigational Site #001017

🇺🇸

Fountain Valley, California, United States

Merz Investigational Site #001184

🇺🇸

Downey, California, United States

Merz Investigational Site #001186

🇺🇸

Chicago, Illinois, United States

Merz Investigational Site #001037

🇺🇸

Augusta, Georgia, United States

Merz Investigational Site #001198

🇺🇸

Stratford, New Jersey, United States

Merz Investigational Site #001211

🇺🇸

Pittsburgh, Pennsylvania, United States

Merz Investigational Site #001226

🇺🇸

Houston, Texas, United States

Merz Investigational Site #420046

🇨🇿

Brno, Czech Republic

Merz Investigational Site #420029

🇨🇿

Brno, Czech Republic

Merz Investigational Site #420028

🇨🇿

Olomouc, Czech Republic

Merz Investigational Site #420024

🇨🇿

Ostrava-Poruba, Czech Republic

Merz Investigational Site #420025

🇨🇿

Pardubice, Czech Republic

Merz Investigational Site #420045

🇨🇿

Praha, Czech Republic

Merz Investigational Site #420047

🇨🇿

Rychnov nad Kneznou, Czech Republic

Merz Investigational Site #036004

🇭🇺

Budapest, Hungary

Merz Investigational Site # 036009

🇭🇺

Budapest, Hungary

Merz Investigational Site #049134

🇩🇪

Rostock, Germany

Merz Investigational Site #036005

🇭🇺

Nyiregyhaza, Hungary

Merz Investigational Site #091006

🇮🇳

Bangalore, Karnataka, India

Merz Investigational Site #036008

🇭🇺

Szeged, Hungary

Merz Investigational Site #091003

🇮🇳

Porur, Chennai, India

Merz Investigational Site #091002

🇮🇳

Trivandrum, Kerala, India

Merz Investigational Site #091001

🇮🇳

Lucknow, Uttar Pradesh, India

Merz Investigational Site #091004

🇮🇳

New Delhi, India

Merz Investigational Site #048044

🇵🇱

Kielce, Poland

Merz Investigational Site #048050

🇵🇱

Lodz, Poland

Merz Investigational Site #048051

🇵🇱

Lublin, Poland

Merz Investigational Site #048031

🇵🇱

Krakow, Poland

Merz Investigational Site #048032

🇵🇱

Olsztyn, Poland

Merz Investigational Site #048023

🇵🇱

Warszawa, Poland

Merz Investigational Site #048052

🇵🇱

Warszawa, Poland

Merz Investigational Site #048033

🇵🇱

Warszawa, Poland

Merz Investigational Site #007010

🇷🇺

Krasnoyarsk, Russian Federation

Merz Investigational Site #007011

🇷🇺

Moscow, Russian Federation

Merz Investigational Site #007009

🇷🇺

St. Petersburg, Russian Federation

Merz Investigational Site #007005

🇷🇺

Stavropol, Russian Federation

Merz Investigational Site #001240

🇺🇸

Chapel Hill, North Carolina, United States

Merz Investigational Site #001241

🇺🇸

Philadelphia, Pennsylvania, United States

Merz Investigational Site #001009

🇺🇸

Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath